AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CME GROUP INC.

Regulatory Filings May 9, 2023

Preview not available for this file type.

Download Source File

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported)

May 9, 2023 ( May 4, 2023 )

CME GROUP INC.

(Exact Name of Registrant as Specified in Charter)

Delaware 001-31553 36-4459170
(State or Other Jurisdiction of Incorporation) (Commission File No.) (IRS Employer Identification No.)

20 South Wacker Drive

Chicago , Illinois 60606

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (312) 930-1000

N/A

(Former Name or Former Address, if Changed Since Last Report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading symbol Name of each exchange on which registered
Class A Common Stock CME Nasdaq

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07. Submission of Matters to a Vote of Security Holders.

CME Group Inc. (the “Company”) held its 2023 Annual Meeting of Shareholders on May 4, 2023 (the “Annual Meeting”).

At the close of business on March 6, 2023, the record date of the Annual Meeting, the Company had 359,742,876 shares of Class A and Class B common stock issued and outstanding. The following shares were present at the Annual Meeting, either in person at the virtual shareholder meeting or by proxy.

Class(es) of Common Stock Aggregate No. of Shares % of the Issued and Outstanding
Classes A and B 310,372,673 86.27%
Class B-1 154 24.64%
Class B-2 185 22.75%
Class B-3 240 18.64%
Class B-4 70 16.94%

The results of the proposals are as follows:

  1. The election of seventeen Equity Directors to serve until 2024 (elected by the Class A and Class B shareholders voting together as a single class):
Name Votes For Against Abstain
Terrence A. Duffy 257,479,451 25,732,170 2,098,057
Kathryn Benesh 282,267,364 2,555,828 486,486
Timothy S. Bitsberger 198,497,526 86,445,091 367,061
Charles P. Carey 155,494,092 129,564,682 250,904
Bryan T. Durkin 267,937,596 17,028,091 343,991
Harold Ford Jr. 281,691,480 3,189,468 428,730
Martin J. Gepsman 235,257,908 49,757,675 294,095
Larry G. Gerdes 230,887,901 53,928,040 493,737
Daniel R. Glickman 176,633,967 108,293,802 381,909
Daniel G. Kaye 273,525,747 11,242,868 541,063
Phyllis M. Lockett 188,837,757 95,728,347 743,574
Deborah J. Lucas 279,035,366 5,735,455 538,857
Terry L. Savage 181,492,942 103,516,285 300,451
Rahael Seifu 208,237,395 76,506,646 565,637
William R. Shepard 259,019,070 25,988,278 302,350
Howard J. Siegel 250,269,690 34,605,690 434,298
Dennis A. Suskind 240,914,215 43,968,153 427,310

There were a total of 25,062,995 broker non-votes in this proposal.

  1. The ratification of the appointment of Ernst & Young LLP as the Company’s independent public accounting firm for 2023 (ratified by the Class A and Class B shareholders voting together as a single class):
Votes For Votes Against Abstentions
288,023,555 22,067,160 281,958
  1. The advisory vote of the compensation of the Company’s named executive officers (by the Class A and Class B shareholders voting together as a single class) was not approved:
Votes For Votes Against Abstentions
91,525,185 192,824,961 959,532

There were a total of 25,062,995 broker non-votes in this proposal.

  1. The advisory vote on the frequency of future advisory votes on the compensation of the Company’s named executive officers of one year was approved:
1 Year 2 Years 3 Years Abstentions
280,593,543 331,495 3,580,093 804,547

There were a total of 25,062,995 broker non-votes in this proposal.

The Board of Directors will follow its recommendation to include a non-binding advisory vote on the compensation of the Company’s named executive officers at each annual meeting until the next required vote on the frequency of future advisory votes on the compensation of the Company’s named executive officers at its 2029 annual meeting.

  1. The election of Class B Directors:

a. In the election of the three Class B-1 Directors, no quorum was achieved. Therefore, William W. Hobert, Patrick J. Mulchrone and Robert J. Tierney Jr. are each a “holdover” under Delaware law and the Company’s bylaws. They will continue to serve until their successors are duly elected at the 2024 Annual Meeting or their earlier resignation or removal.

Name Votes For Votes Against Abstentions
William W. Hobert 145 4 5
Patrick J. Mulchrone 150 1 3
Robert J. Tierney Jr. 147 4 3

a. In the election of the two Class B-2 Directors, no quorum was achieved. Therefore, Michael G. Dennis and Patrick W. Maloney are each a “holdover” under Delaware law and the Company’s bylaws. They will continue to serve until their successors are duly elected at the 2024 Annual Meeting or their earlier resignation or removal.

Name Votes For Votes Against Abstentions
Michael G. Dennis 166 12 7
Patrick W. Maloney 172 7 6

b. In the election of one Class B-3 Director, no quorum was achieved. Therefore, Elizabeth A. Cook is a “holdover” under Delaware law and the Company’s bylaws. She will continue to serve until her successor is duly elected at the 2024 Annual Meeting or her earlier resignation or removal.

Name Votes For Votes Against Abstentions
Elizabeth A. Cook 201 34 5

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CME Group Inc.
Registrant
Date: May 9, 2023 By: /s/ Jonathan Marcus
Name: Jonathan Marcus
Title: Senior Managing Director and
General Counsel

Talk to a Data Expert

Have a question? We'll get back to you promptly.